Cellebrite DI (CLBT) Long-Term Investments (2022 - 2025)

Cellebrite DI has reported Long-Term Investments over the past 4 years, most recently at $98.0 million for Q4 2025.

  • Quarterly results put Long-Term Investments at $98.0 million for Q4 2025, up 167.64% from a year ago — trailing twelve months through Dec 2025 was $98.0 million (up 167.64% YoY), and the annual figure for FY2025 was $98.0 million, up 167.64%.
  • Long-Term Investments for Q4 2025 was $98.0 million at Cellebrite DI, up from $36.6 million in the prior quarter.
  • Over the last five years, Long-Term Investments for CLBT hit a ceiling of $98.0 million in Q4 2025 and a floor of $22.1 million in Q4 2022.
  • Median Long-Term Investments over the past 4 years was $32.7 million (2023), compared with a mean of $46.4 million.
  • Biggest five-year swings in Long-Term Investments: grew 26.83% in 2024 and later soared 167.64% in 2025.
  • Cellebrite DI's Long-Term Investments stood at $22.1 million in 2022, then surged by 30.44% to $28.9 million in 2023, then rose by 26.83% to $36.6 million in 2024, then soared by 167.64% to $98.0 million in 2025.
  • The last three reported values for Long-Term Investments were $98.0 million (Q4 2025), $36.6 million (Q4 2024), and $28.9 million (Q4 2023) per Business Quant data.